Inside Innovation

London-based Tenpoint Therapeutics, which has its U.S. headquarters in Seattle, raised $235 million as it prepares to launch its lead eye drop treatment for presbyopia.

The Brotman Baty Institute and the Seattle Hub for Synthetic Biology have selected the first eight postdoctoral researchers for the SeaBridge Fellowship, a new translational

The Gates Foundation and OpenAI are launching a $50 million partnership to deploy artificial intelligence tools in frontline primary health care clinics across Africa, beginning

Pacific Northwest Research Institute (PNRI) researchers have shown that two harmful genetic variants can restore normal function when present together, experimentally validating a decades-old hypothesis

Jubilant HollisterStier plans to expand its Spokane campus with a new $18.5 million building to relocate its allergens processing business unit. The proposed two-story structure

InduPro has entered a collaboration with Eli Lilly to discover new cancer treatments through a deal that could be worth up to $950 million. Under

Variant Bio has launched an AI-powered platform designed to discover new drug candidates using human genetic data. The private biotech company said its Inference platform

Bellevue-based TerraPower announced a deal with Meta to build up to eight small modular nuclear reactors in the U.S. to supply clean energy for the

Seattle-based Alpenglow Biosciences announced a partnership with PathNet to bring its 3D microscope technology into clinical pathology labs to modernize diagnostics for prostate and bladder

Scientists at the Allen Institute and HHMI’s Janelia Research Campus engineered a protein that can record the incoming chemical signals of brain cells, enabling researchers

Adaptive Biotechnologies announced two non-exclusive agreements with Pfizer to advance immune receptor discovery and data access. Pfizer will use Adaptive’s platform to identify disease-driving T-cell

Seattle startup Rhizome Research is building AI systems to design made-to-order small drug-like molecules for drug discovery. Founded by former Amazon AI engineer Xhuliano Brace,